Filtros de búsqueda

Lista de obras de Helen Heslop

"Mini" bank of only 8 donors supplies CMV-directed T cells to diverse recipients

artículo científico publicado en 2019

A backpack revs up T-cell activity

artículo científico publicado en 2018

A chimeric T cell antigen receptor that augments cytokine release and supports clonal expansion of primary human T cells

artículo científico publicado en 2005

A less sour sweet; blocking galectin ⬇️

artículo científico publicado el 21 de abril de 2011

A method for preparing leucocyte depleted erythrocytes from rat blood ⬇️

artículo científico publicado el 1 de enero de 1978

A phase 2/3 multicenter randomized clinical trial of ABX-CBL versus ATG as secondary therapy for steroid-resistant acute graft-versus-host disease

artículo científico publicado en 2007

A phase I clinical trial of recombinant interleukin 2 following high dose chemo-radiotherapy for haematological malignancy: applicability to the elimination of minimal residual disease

artículo científico publicado en 1989

A single institution experience with pediatric nasopharyngeal carcinoma: high incidence of toxicity associated with platinum-based chemotherapy plus IMRT.

artículo científico publicado en 2007

A strategy for treatment of Epstein-Barr virus-positive Hodgkin's disease by targeting interleukin 12 to the tumor environment using tumor antigen-specific T cells

artículo científico publicado en 2004

ASBMT committee report: white paper on measurement of quality outcomes

artículo científico publicado en 2006

Accelerated production of antigen-specific T cells for preclinical and clinical applications using gas-permeable rapid expansion cultureware (G-Rex).

artículo científico publicado en 2010

Activity of broad-spectrum T cells as treatment for AdV, EBV, CMV, BKV, and HHV6 infections after HSCT.

artículo científico publicado en 2014

Adapting a transforming growth factor beta-related tumor protection strategy to enhance antitumor immunity.

artículo científico publicado en 2002

Add-back of allodepleted donor T cells to improve immune reconstitution after haplo-identical stem cell transplantation

artículo científico publicado en 2005

Adenoviral gene transfer into dendritic cells efficiently amplifies the immune response to LMP2A antigen: a potential treatment strategy for Epstein-Barr virus--positive Hodgkin's lymphoma

artículo científico publicado en 2001

Adenovirus infection after pediatric bone marrow transplantation

artículo científico publicado en 1999

Adenovirus infection rates in pediatric recipients of alternate donor allogeneic bone marrow transplants receiving either antithymocyte globulin (ATG) or alemtuzumab (Campath).

artículo científico publicado en 2005

Administration of latent membrane protein 2-specific cytotoxic T lymphocytes to patients with relapsed Epstein-Barr virus-positive lymphoma

artículo científico publicado en 2006

Administration of neomycin resistance gene marked EBV specific cytotoxic T-lymphocytes to patients with relapsed EBV-positive Hodgkin disease.

artículo científico publicado en 1998

Administration of neomycin resistance gene-marked EBV-specific cytotoxic T-lymphocytes as therapy for patients receiving a bone marrow transplant for relapsed EBV-positive Hodgkin disease

artículo científico publicado en 2000

Administration of neomycin-resistance-gene-marked EBV-specific cytotoxic T lymphocytes to recipients of mismatched-related or phenotypically similar unrelated donor marrow grafts

artículo científico publicado en 1994

Adoptive Immunotherapy with Antigen-Specific T Cells Expressing a Native TCR

scientific article published on 01 April 2019

Adoptive T cell therapy of cancer

artículo científico publicado en 2010

Adoptive T-cell therapy for EBV-associated post-transplant lymphoproliferative disease

artículo científico publicado en 2003

Adoptive T-cell therapy for Epstein-Barr virus-positive Hodgkin's disease

artículo científico publicado en 2003

Adoptive T-cell transfer in cancer immunotherapy

artículo científico publicado en 2006

Adoptive cellular immunotherapy for EBV lymphoproliferative disease

artículo científico publicado en 1997

Adoptive cellular immunotherapy for viral diseases

artículo científico publicado en 2007

Adoptive cellular therapy with T cells specific for EBV-derived tumor antigens

artículo científico

Adoptive immunotherapy for EBV-associated malignancies

scientific article published on 01 January 2005

Adoptive immunotherapy for Epstein-Barr virus-related lymphoma

artículo científico publicado en 1996

Adoptive immunotherapy for posttransplantation viral infections

artículo científico publicado en 2004

Adoptive immunotherapy for primary immunodeficiency disorders with virus-specific T lymphocytes

artículo científico publicado en 2016

Adoptive immunotherapy of EBV-associated malignancies with EBV-specific cytotoxic T-cell lines

artículo científico publicado en 2001

Adoptive immunotherapy with allodepleted donor T-cells improves immune reconstitution after haploidentical stem cell transplantation

artículo científico publicado en 2006

Adoptive transfer of EBV-specific T cells results in sustained clinical responses in patients with locoregional nasopharyngeal carcinoma

artículo científico publicado en 2010

Adoptive transfer of rapidly-generated multivirus-specific T cells to treat Adv, EBV, CMV, BK and HHV6 infections of HSCT recipients

artículo científico publicado en 2013

Adverse events following infusion of T cells for adoptive immunotherapy: a 10-year experience

artículo científico publicado en 2010

Aggressive peripheral CD70-positive T-cell lymphoma associated with severe chronic active EBV infection

artículo científico publicado en 2011

Allogeneic bone marrow transplantation for children with histiocytic disorders: use of TBI and omission of etoposide in the conditioning regimen

artículo científico publicado en 2003

Allogeneic bone marrow transplantation in children failing prior autologous bone marrow transplantation

artículo científico publicado en 2001

Allogeneic haematopoietic cell transplantation for myelofibrosis in 30 patients 60–78 years of age ⬇️

artículo científico publicado el 17 de febrero de 2011

Allogeneic hematopoietic stem cell transplant for relapsed and refractory non-Hodgkin lymphoma in pediatric patients

scientific article published on 01 September 2019

Allogeneic virus-specific T cells with HLA alloreactivity do not produce GVHD in human subjects

artículo científico publicado en 2010

An Epstein-Barr virus deletion mutant associated with fatal lymphoproliferative disease unresponsive to therapy with virus-specific CTLs

artículo científico publicado en 2001

An inducible caspase 9 safety switch for T-cell therapy

artículo científico publicado en 2005

An inducible caspase 9 suicide gene to improve the safety of mesenchymal stromal cell therapies

artículo científico publicado en 2010

Anti-CD30 CAR-T Cell Therapy in Relapsed and Refractory Hodgkin Lymphoma

scientific article published on 23 July 2020

Anti-pan T lymphocyte ricin A chain immunotoxin (H65-RTA) and methylprednisolone for acute GVHD prophylaxis following allogeneic BMT from HLA-identical sibling donors

scientific article published on 01 January 1993

Antigen-specific T cell therapies for cancer

artículo científico

Antigen-specific cytotoxic T lymphocytes can target chemoresistant side-population tumor cells in Hodgkin lymphoma

artículo científico publicado en 2010

Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastoma

artículo científico publicado en 2011

Antitumor activity of EBV-specific T lymphocytes transduced with a dominant negative TGF-beta receptor

artículo científico publicado en 2008

Antiviral T-cell therapy

artículo científico publicado en 2014

Assessing the safety of cytotoxic T lymphocytes transduced with a dominant negative transforming growth factor-beta receptor.

artículo científico publicado en 2006

Assessment of the efficacy of purging by using gene marked autologous marrow transplantation for children with AML in first complete remission

artículo científico publicado en 1994

Autologous Epstein-Barr virus (EBV)-specific cytotoxic T cells for the treatment of persistent active EBV infection

artículo científico publicado en 2002

Autologous HER2 CMV bispecific CAR T cells are safe and demonstrate clinical benefit for glioblastoma in a Phase I trial

artículo científico publicado en 2015

Biology and treatment of Epstein-Barr virus-associated non-Hodgkin lymphomas

artículo científico publicado en 2005

Blood and Marrow Transplant Clinical Trials Network State of the Science Symposium 2007

artículo científico publicado en 2007

Blood and marrow transplant clinical trials network state of the Science Symposium 2014

artículo científico publicado en 2014

Bone marrow transplantation for therapy-induced acute myeloid leukemia in children with previous lymphoid malignancies

artículo científico publicado en 1999

Bronchiolitis obliterans organizing pneumonia (BOOP) in children after allogeneic bone marrow transplantation

artículo científico publicado en 1994

CAR T Cells Administered in Combination with Lymphodepletion and PD-1 Inhibition to Patients with Neuroblastoma

artículo científico publicado en 2017

CAR-T Cell Therapy for Lymphoma.

artículo científico publicado en 2015

CAR-T cell Therapy for Non-Hodgkin Lymphomas: A New Treatment Paradigm

scientific article published on 28 March 2019

CARs on track in the clinic

artículo científico publicado en 2011

CD20 monoclonal antibody (rituximab) for therapy of Epstein-Barr virus lymphoma after hemopoietic stem-cell transplantation

artículo científico publicado en 2000

CD28 costimulation improves expansion and persistence of chimeric antigen receptor-modified T cells in lymphoma patients

artículo científico publicado en 2011

CD52 and CD45 monoclonal antibodies for reduced intensity hemopoietic stem cell transplantation from HLA matched and one antigen mismatched unrelated donors

artículo científico publicado en 2005

CMV-specific T cells generated from naïve T cells recognize atypical epitopes and may be protective in vivo

artículo científico publicado en 2015

CRISPR-Edited Immune Effectors: The End of the Beginning

artículo científico publicado en 2020

Cellular immunity to Epstein-Barr virus in liver transplant recipients treated with rituximab for post-transplant lymphoproliferative disease

artículo científico publicado en 2005

Cellular therapy of Epstein-Barr-virus-associated post-transplant lymphoproliferative disease

artículo científico publicado en 2004

Characteristics of T-cell receptor repertoire and myelin-reactive T cells reconstituted from autologous haematopoietic stem-cell grafts in multiple sclerosis

artículo científico publicado en 2004

Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States

artículo científico publicado en 2011

Characterization of latent membrane protein 2 specificity in CTL lines from patients with EBV-positive nasopharyngeal carcinoma and lymphoma

artículo científico publicado en 2005

Checkpoint inhibition and cellular immunotherapy in lymphoma

artículo científico publicado en 2016

Children with acute leukemia: A comparison of outcomes from allogeneic blood stem cell and bone marrow transplantation ⬇️

artículo científico publicado el 1 de enero de 2011

Clinical Utilization of Chimeric Antigen Receptor T Cells in B Cell Acute Lymphoblastic Leukemia: An Expert Opinion from the European Society for Blood and Marrow Transplantation and the American Society for Blood and Marrow Transplantation

artículo científico publicado en 2018

Clinical and immunological responses after CD30-specific chimeric antigen receptor-redirected lymphocytes

artículo científico publicado en 2017

Clinical effects of administering leukemia-specific donor T cells to patients with AML/MDS post-allogeneic transplant

artículo científico publicado en 2020

Clinical responses with T lymphocytes targeting malignancy-associated κ light chains

artículo científico publicado en 2016

Clinical utilization of Chimeric Antigen Receptor T-cells (CAR-T) in B-cell acute lymphoblastic leukemia (ALL)-an expert opinion from the European Society for Blood and Marrow Transplantation (EBMT) and the American Society for Blood and Marrow Tran

scientific article published on 15 May 2019

Clonal Dynamics In Vivo of Virus Integration Sites of T Cells Expressing a Safety Switch

artículo científico publicado en 2015

Closely related T-memory stem cells correlate with in vivo expansion of CAR.CD19-T cells and are preserved by IL-7 and IL-15

artículo científico publicado en 2014

Co-expression of cytokine and suicide genes to enhance the activity and safety of tumor-specific cytotoxic T lymphocytes.

artículo científico publicado en 2007

Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma.

artículo científico publicado en 2013

Combining drugs and biologics to treat nasopharyngeal cancer

scientific article published on January 2014

Commentary on journal of immunotherapy paper by melenhorst et al

artículo científico publicado en 2006

Comparable outcome of alternative donor and matched sibling donor hematopoietic stem cell transplant for children with acute lymphoblastic leukemia in first or second remission using alemtuzumab in a myeloablative conditioning regimen

artículo científico publicado en 2008

Comparable outcomes of matched-related and alternative donor stem cell transplantation for pediatric severe aplastic anemia

artículo científico publicado en 2006

Comparison of the efficiency of transduction of leukemic cells by fiber-modified adenoviruses.

artículo científico publicado en 2004

Comparison of two CD40-ligand/interleukin-2 vaccines in patients with chronic lymphocytic leukemia ⬇️

artículo científico publicado el 12 de julio de 2011

Complement-fixing CD45 monoclonal antibodies to facilitate stem cell transplantation in mouse and man.

artículo científico publicado en 2003

Complementation of antigen-presenting cells to generate T lymphocytes with broad target specificity

artículo científico publicado en 2014

Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transfer

artículo científico publicado en 2007

Computer-assisted quantitative evaluation of therapeutic responses for lymphoma using serial PET/CT imaging

artículo científico publicado en 2010

Control of virus-induced lymphoproliferation: Epstein-Barr virus-induced lymphoproliferation and host immunity

artículo científico publicado en 1997

Correction of Duncan's syndrome by allogeneic bone marrow transplantation

scientific article published on 01 September 1993

Crosstalk between Medulloblastoma Cells and Endothelium Triggers a Strong Chemotactic Signal Recruiting T Lymphocytes to the Tumor Microenvironment ⬇️

artículo científico publicado el 27 de mayo de 2011

Current Allogeneic Hematopoietic Stem Cell Transplantation for Pediatric Acute Lymphocytic Leukemia: Success, Failure and Future Perspectives-A Single-Center Experience, 2008 to 2016.

artículo científico publicado en 2018

Current status of genetic modification of T cells for cancer treatment

artículo científico publicado en 2005

Cytomegalovirus (CMV) infections and CMV-specific cellular immune reconstitution following reduced intensity conditioning allogeneic stem cell transplantation with Alemtuzumab

artículo científico publicado en 2005

Cytotoxic T lymphocyte therapy for Epstein-Barr virus+ Hodgkin's disease

artículo científico publicado en 2004

Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantation

artículo científico publicado en 2009

Cytotoxic T lymphocytes as immune-therapy in haematological practice

artículo científico publicado en 2008

Cytotoxic T lymphocytes directed to the preferentially expressed antigen of melanoma (PRAME) target chronic myeloid leukemia

artículo científico publicado en 2008

Cytotoxic T lymphocytes simultaneously targeting multiple tumor-associated antigens to treat EBV negative lymphoma

artículo científico publicado en 2011

Definitions of histocompatibility typing terms ⬇️

artículo científico publicado el 14 de octubre de 2011

Definitions of histocompatibility typing terms: Harmonization of Histocompatibility Typing Terms Working Group ⬇️

artículo científico publicado el 15 de junio de 2011

Delayed Induction of Proto-Oncogene Expression in B-CLL Cells by Tumor Necrosis Factor

artículo científico publicado en 1990

Derivation of human T lymphocytes from cord blood and peripheral blood with antiviral and antileukemic specificity from a single culture as protection against infection and relapse after stem cell transplantation

artículo científico publicado en 2010

Diagnosis and treatment of posttransplantation lymphoproliferative disease after hematopoietic stem cell transplantation

artículo científico publicado en 2002

Direct demonstration that autologous bone marrow transplantation for solid tumors can return a multiplicity of tumorigenic cells.

artículo científico publicado en 1994

Donor T cells to treat EBV-associated lymphoma

scientific article published on 01 September 1994

EBV specific CTL: a model for immune therapy

artículo científico publicado en 1998

EBV/LMP-specific T cells maintain remissions of T- and B-cell EBV lymphomas after allogeneic bone marrow transplantation

artículo científico publicado en 2018

Early identification of Epstein-Barr virus-associated post-transplantation lymphoproliferative disease

artículo científico publicado en 1995

Effects of interferon alpha on autocrine growth factor loops in B lymphoproliferative disorders

artículo científico publicado en 1990

Effects of recombinant interleukin-2 administration on cytotoxic function following high-dose chemo-radiotherapy for hematological malignancy

artículo científico publicado en 1989

Effects of tumour necrosis factor and alpha interferon on chronic B cell malignancies

artículo científico publicado en 1988

Efficacy of deferred dosing of granulocyte colony-stimulating factor in autologous hematopoietic transplantation for multiple myeloma.

artículo científico publicado en 2013

Efficient infection of primitive hematopoietic stem cells by modified adenovirus

artículo científico publicado en 2001

Endogenously generated activated killer cells circulate after autologous and allogeneic marrow transplantation but not after chemotherapy

scientific article published on 01 April 1989

Energy expenditure in children undergoing hematopoietic stem cell transplantation

artículo científico publicado en 2002

Engineered off-the-shelf therapeutic T cells resist host immune rejection

scientific article published on 13 July 2020

Engineering CD19-specific T lymphocytes with interleukin-15 and a suicide gene to enhance their anti-lymphoma/leukemia effects and safety

artículo científico publicado en 2010

Enhancement of monoclonal antibody dependent cell mediated cytotoxicity by IL2 and GM-CSF

scientific article published on 01 December 1989

Enhancing the in vivo expansion of adoptively transferred EBV-specific CTL with lymphodepleting CD45 monoclonal antibodies in NPC patients

artículo científico publicado en 2008

Epigenetic Inhibition Puts Target Antigen in the Crosshairs of CAR T Cells

artículo científico publicado en 2019

Epipodophyllotoxin-related acute myeloid leukemia: a study of 35 cases

artículo científico publicado en 1995

Epstein Barr virus specific cytotoxic T lymphocytes expressing the anti-CD30zeta artificial chimeric T-cell receptor for immunotherapy of Hodgkin disease

artículo científico publicado en 2007

Epstein-Barr infection after bone marrow transplantation

scientific article published on 01 March 1994

Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes for the prevention and treatment of EBV-associated post-transplant lymphomas

artículo científico publicado en 2002

Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes for the treatment of patients with EBV-positive relapsed Hodgkin's disease ⬇️

artículo científico publicado el 15 de abril de 1998

Epstein-Barr virus lymphoproliferative disease after hematopoietic stem cell transplant

artículo científico publicado en 2014

Equal opportunity CAR T cells

artículo científico publicado en 2017

Equal-opportunity treatment of EBV-PTLD ⬇️

artículo científico publicado el 15 de marzo de 2012

Evidence for the presentation of major histocompatibility complex class I-restricted Epstein-Barr virus nuclear antigen 1 peptides to CD8+ T lymphocytes

artículo científico publicado en 2004

Ex vivo gene transfer for improved adoptive immunotherapy of cancer

artículo científico publicado en 2011

Excellent survival after sibling or unrelated donor stem cell transplantation for chronic granulomatous disease

artículo científico publicado en 2011

Exhausting alloreactivity of donor-derived CAR T cells

artículo científico publicado en 2017

Expansion of EBV latent membrane protein 2a specific cytotoxic T cells for the adoptive immunotherapy of EBV latency type 2 malignancies: influence of recombinant IL12 and IL15

artículo científico publicado en 2003

Expansion of T cells targeting multiple antigens of cytomegalovirus, Epstein-Barr virus and adenovirus to provide broad antiviral specificity after stem cell transplantation

artículo científico publicado en 2011

Exploiting cytokine secretion to rapidly produce multivirus-specific T cells for adoptive immunotherapy

artículo científico publicado en 2008

Fall of the mutants: T cells targeting BCR-ABL.

artículo científico publicado en 2017

Fine-tuning the CAR spacer improves T-cell potency

artículo científico publicado en 2016

Flanking-sequence exponential anchored-polymerase chain reaction amplification: a sensitive and highly specific method for detecting retroviral integrant-host-junction sequences

artículo científico publicado en 2008

Forecasting Cytokine Storms with New Predictive Biomarkers

artículo científico publicado en 2016

Functionally active virus-specific T cells that target CMV, adenovirus, and EBV can be expanded from naive T-cell populations in cord blood and will target a range of viral epitopes

artículo científico publicado en 2009

Gamma delta T lymphocyte regeneration after T lymphocyte-depleted bone marrow transplantation from mismatched family members or matched unrelated donors

scientific article published on 01 February 1996

Gamma-interferon and tumor necrosis factor production after bone marrow transplantation is augmented by exposure to marrow fibroblasts infected with cytomegalovirus

artículo científico publicado en 1990

Gene and cell transfer for specific immunotherapy

artículo científico publicado en 1998

Gene marking after bone marrow transplantation.

artículo científico publicado en 1994

Gene marking and autologous bone marrow transplantation

artículo científico publicado en 1994

Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patients

scientific article published on 01 November 1993

Gene therapy for paediatric leukaemia ⬇️

artículo científico publicado el 1 de julio de 2001

Gene transfer and bone marrow transplantation

artículo científico publicado en 1994

Gene transfer into human hemopoietic progenitor cells

artículo científico publicado en 1995

Gene-marked autologous hematopoietic stem cell transplantation of autoimmune disease

artículo científico publicado en 2000

Gene-marking and haemopoietic stem-cell transplantation

artículo científico publicado en 1995

Gene-marking studies of hematopoietic cells

artículo científico publicado en 2001

Generating CTLs against the subdominant Epstein-Barr virus LMP1 antigen for the adoptive immunotherapy of EBV-associated malignancies

artículo científico publicado en 2002

Generation of EBV-specific CD4+ cytotoxic T cells from virus naive individuals

artículo científico publicado en 2002

Generation of Epstein-Barr virus-specific cytotoxic T lymphocytes resistant to the immunosuppressive drug tacrolimus (FK506)

artículo científico publicado en 2009

Generation of autologous Epstein-Barr virus-specific cytotoxic T cells for adoptive immunotherapy in solid organ transplant recipients

artículo científico publicado en 2001

Generation of multivirus-specific T cells by a single stimulation of peripheral blood mononuclear cells with a peptide mixture using serum-free medium

artículo científico publicado en 2018

Generation of polyclonal CMV-specific T cells for the adoptive immunotherapy of glioblastoma

artículo científico publicado en 2012

Genetic and mechanistic diversity in pediatric hemophagocytic lymphohistiocytosis.

artículo científico publicado en 2018

Genetic engineering of T-cell receptors: TCR takes to titin ⬇️

artículo científico publicado el 8 de agosto de 2013

Genetic manipulation of tumor-specific cytotoxic T lymphocytes to restore responsiveness to IL-7.

artículo científico publicado en 2009

Genetic modification of T cells

artículo científico publicado en 2011

Genetically engineered T-cells for adoptive immunotherapy.

artículo científico publicado en 2002

Getting Personal with Melanoma ⬇️

artículo científico publicado el 28 de junio de 2011

Go-CART: an animal-free system for the assessment of CAR T cell function.

artículo científico publicado en 2015

Graft versus leukaemia effects after marrow transplantation in man.

scientific article published on July 1991

Graft versus leukemia response without graft-versus-host disease elicited by adoptively transferred multivirus-specific T-cells

artículo científico publicado en 2014

Graft-versus-host reactions and bone-marrow transplantation ⬇️

artículo científico publicado el 1 de octubre de 1991

Guidance for developing phase II cell therapy trial proposals for consideration by the Blood and Marrow Transplant Clinical Trials Network

artículo científico publicado en 2010

Guillain-Barré syndrome after allogeneic hematopoietic stem cell transplantation

artículo científico publicado en 2002

HER2-Specific Chimeric Antigen Receptor-Modified Virus-Specific T Cells for Progressive Glioblastoma: A Phase 1 Dose-Escalation Trial

artículo científico publicado en 2017

HER2-specific T cells target primary glioblastoma stem cells and induce regression of autologous experimental tumors

artículo científico publicado en 2010

Haemopoietic stem cell transplantation for acute lymphoblastic leukaemia

artículo científico publicado en 2003

Harmonizing Immune Effector Toxicity Reporting

artículo científico publicado en 2019

Hematopoietic and immunomodulatory effects of lytic CD45 monoclonal antibodies in patients with hematologic malignancy

artículo científico publicado en 2003

Hematopoietic stem cell transplantation in patients with sporadic amyotrophic lateral sclerosis

artículo científico publicado en 2008

Hemolytic uremic syndrome after bone marrow transplantation: clinical characteristics and outcome in children

artículo científico publicado en 2005

Hemorrhagic cystitis after allogeneic bone marrow transplantation in children: clinical characteristics and outcome

artículo científico publicado en 2003

High Incidence of Autoimmune Disease after Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease

artículo científico publicado en 2018

High-avidity cytotoxic T lymphocytes specific for a new PRAME-derived peptide can target leukemic and leukemic-precursor cells

artículo científico publicado en 2011

Homeostatic action of interleukin-4 on endogenous and recombinant interleukin-2-induced activated killer cell function

artículo científico publicado en 1991

How I treat EBV lymphoproliferation

artículo científico publicado en 2009

Human Epidermal Growth Factor Receptor 2 (HER2) -Specific Chimeric Antigen Receptor-Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma

artículo científico publicado en 2015

Human gene marker/therapy clinical protocols

artículo científico publicado en 1996

Human gene marker/therapy clinical protocols

artículo científico publicado en 1996

Human gene marker/therapy clinical protocols

scientific article published on 01 December 1999

Human gene marker/therapy clinical protocols

scientific article published on 01 April 2000

Human gene marker/therapy clinical protocols

artículo científico publicado en 1997

Human herpesvirus-6 encephalitis following allogeneic hematopoietic stem cell transplantation

artículo científico publicado en 2007

Human papillomavirus type 16 E6/E7-specific cytotoxic T lymphocytes for adoptive immunotherapy of HPV-associated malignancies.

artículo científico publicado en 2013

IL-2 infusion abrogates humoral immune responses in humans

artículo científico publicado en 1992

Identification of HLA-DP3-restricted peptides from EBNA1 recognized by CD4(+) T cells.

artículo científico publicado en 2002

Identification of hexon-specific CD4 and CD8 T-cell epitopes for vaccine and immunotherapy

artículo científico publicado en 2007

Immune therapy for EBV infections after hemopoietic stem-cell transplant

artículo científico publicado en 2002

Immunotherapeutic strategies to prevent and treat human herpesvirus 6 reactivation after allogeneic stem cell transplantation

artículo científico publicado en 2012

Immunotherapy for Epstein-Barr virus-associated cancers

artículo científico publicado en 1998

Immunotherapy for Epstein-Barr virus-associated cancers in children

artículo científico publicado en 2003

Immunotherapy for Hodgkin's disease.

artículo científico publicado en 2002

Immunotherapy for epstein-barr virus-related lymphomas ⬇️

artículo científico publicado el 17 de noviembre de 2009

Immunotherapy for osteosarcoma: genetic modification of T cells overcomes low levels of tumor antigen expression.

artículo científico publicado en 2009

Immunotherapy for post-transplant lymphoproliferative disease

artículo científico publicado en 2002

Immunotherapy of hematologic malignancy.

artículo científico publicado en 2003

Immunotherapy of high-risk acute leukemia with a recipient (autologous) vaccine expressing transgenic human CD40L and IL-2 after chemotherapy and allogeneic stem cell transplantation.

artículo científico publicado en 2005

Immunotherapy of leukemia

artículo científico publicado en 1992

Immunotherapy targeting EBV-expressing lymphoproliferative diseases

artículo científico publicado en 2008

Immunotherapy to reconstitute immunity to DNA viruses

artículo científico publicado en 2002

Immunotherapy: opportunities, risks and future perspectives

artículo científico publicado en 2014

Impending challenges in the hematopoietic stem cell transplantation physician workforce

artículo científico publicado en 2009

Improving Chimeric Antigen Receptor-Modified T Cell Function by Reversing the Immunosuppressive Tumor Microenvironment of Pancreatic Cancer

artículo científico publicado en 2017

Improving T-cell therapy for relapsed EBV-negative Hodgkin lymphoma by targeting upregulated MAGE-A4

artículo científico publicado en 2011

In Vivo Fate and Activity of Second- versus Third-Generation CD19-Specific CAR-T Cells in B Cell Non-Hodgkin's Lymphomas

scientific article published on 13 September 2018

In vitro analysis of the interactions of recombinant IL-2 with regenerating lymphoid and myeloid cells after allogeneic marrow transplantation

artículo científico publicado en 1988

In vivo expansion of LMP 1- and 2-specific T-cells in a patient who received donor-derived EBV-specific T-cells after allogeneic stem cell transplantation

artículo científico publicado en 2006

In vivo induction of gamma interferon and tumor necrosis factor by interleukin-2 infusion following intensive chemotherapy or autologous marrow transplantation

scientific article published on 01 September 1989

Incorporation of thiotepa in a reduced intensity conditioning regimen may improve engraftment after transplant for HLH

scientific article published on 27 January 2020

Increased transduction efficiency of primary hematopoietic cells by physical colocalization of retrovirus and target cells

artículo científico publicado en 1998

Increasing the purity, potency and specificity of ebv-specific T cells to improve the treatment of EBV-positive lymphoma

artículo científico publicado en 2015

Inducible apoptosis as a safety switch for adoptive cell therapy

artículo científico publicado en 2011

Inducible caspase 9 suicide gene to improve the safety of allodepleted T cells after haploidentical stem cell transplantation

artículo científico publicado en 2007

Inducible caspase-9 suicide gene controls adverse effects from alloreplete T cells after haploidentical stem cell transplantation

artículo científico publicado en 2015

Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients ⬇️

artículo científico publicado el 1 de septiembre de 1998

Infusion of donor-derived CD19-redirected virus-specific T cells for B-cell malignancies relapsed after allogeneic stem cell transplant: a phase 1 study

scientific article published on 12 September 2013

Intensive chemotherapy with hematopoietic stem-cell support for children with recurrent or refractory NHL

artículo científico publicado en 2002

Interleukin 15 provides relief to CTLs from regulatory T cell-mediated inhibition: implications for adoptive T cell-based therapies for lymphoma

artículo científico publicado en 2012

Interleukin 2 infusion induces haemopoietic growth factors and modifies marrow regeneration after chemotherapy or autologous marrow transplantation

scientific article published on 01 February 1991

Interleukin-2 infusion after autologous bone marrow transplantation enhances hemopoietic regeneration

artículo científico publicado en 1991

Intravenous Cidofovir therapy for disseminated adenovirus in a pediatric liver transplant recipient

artículo científico publicado en 2002

Is retroviral gene marking too dangerous to use?

scientific article published on 01 January 2003

Kinetics of tumor destruction by chimeric antigen receptor-modified T cells

artículo científico publicado en 2013

Large-scale expansion of dendritic cell-primed polyclonal human cytotoxic T-lymphocyte lines using lymphoblastoid cell lines for adoptive immunotherapy

artículo científico publicado en 2003

Late-onset severe chronic active EBV in a patient for five years with mutations in STXBP2 (MUNC18-2) and PRF1 (perforin 1).

artículo científico publicado en 2015

Long-term outcome after haploidentical stem cell transplant and infusion of T cells expressing the inducible caspase 9 safety transgene

artículo científico publicado en 2014

Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients

artículo científico publicado en 2009

Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes

artículo científico publicado en 1996

Lymphoproliferative disorders involving Epstein-Barr virus after hemopoietic stem cell transplantation

artículo científico publicado en 1999

Malignant plasma cells are sensitive to LAK cell lysis: pre-clinical and clinical studies of interleukin 2 in the treatment of multiple myeloma

artículo científico publicado en 1990

Modulating TNFα activity allows transgenic IL15-Expressing CLL-1 CAR T cells to safely eliminate acute myeloid leukemia

scientific article published on 01 September 2020

Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals

artículo científico publicado en 2006

Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation

artículo científico publicado en 2013

Neuropathic dermatomes and cutaneous ulceration in patients with chronic GVHD.

artículo científico publicado en 2014

New ISSCR guidelines: clinical translation of stem cell research

artículo científico publicado en 2016

New approaches in alternative donor transplantation

artículo científico

Nucleofection of DCs to generate Multivirus-specific T cells for prevention or treatment of viral infections in the immunocompromised host.

artículo científico publicado en 2009

Off-the-Shelf Virus-Specific T Cells to Treat BK Virus, Human Herpesvirus 6, Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections After Allogeneic Hematopoietic Stem-Cell Transplantation

artículo científico publicado en 2017

Optimizing the production of suspension cells using the G-Rex "M" series

artículo científico publicado en 2014

Options for T-cell based therapies

artículo científico publicado en 2004

Outcome of hematopoietic stem cell transplant as salvage therapy for Hodgkin's lymphoma in adolescents and young adults at a single institution

artículo científico publicado en 2010

Outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation (RISCT) using antilymphocyte antibodies in patients with high-risk acute myeloid leukemia (AML)

scientific article published on 01 March 2006

Outcomes after Allogeneic Transplant in Patients with Wiskott-Aldrich Syndrome

artículo científico publicado en 2017

Outcomes after Second Hematopoietic Stem Cell Transplantations in Pediatric Patients with Relapsed Hematological Malignancies

artículo científico publicado en 2015

Outcomes of transplantation with matched-sibling and unrelateddonor bone marrow in children with leukaemia ⬇️

artículo científico publicado el 13 de septiembre de 1997

Pharmacotherapy versus T lymphocytes for CMV ⬇️

artículo científico publicado el 2 de mayo de 2013

Phase I study of chemokine and cytokine gene-modified autologous neuroblastoma cells for treatment of relapsed/refractory neuroblastoma using an adenoviral vector

artículo científico publicado en 2000

Plasma Markers of B-Cell Activation and Clonality in Pediatric Liver and Hematopoietic Stem Cell Transplant Recipients ⬇️

artículo científico publicado el 15 de febrero de 2013

Policy: Global standards for stem-cell research

artículo científico publicado en 2016

Possible mechanism of action of interferon alpha in chronic B-cell malignancies

artículo científico publicado en 1991

Possible mechanism of selective killing of myeloid leukemic blast cells by lymphokine-activated killer cells ⬇️

artículo científico publicado el 1 de mayo de 1991

Post-transplant lymphoproliferative disorders

artículo científico publicado en 2005

Posttransplant lymphoproliferative disease following liver transplantation

artículo científico publicado en 2011

Preparing for growth: current capacity and challenges in hematopoietic stem cell transplantation programs

artículo científico publicado en 2010

Priorities for Improving Outcomes for Nonmalignant Blood Diseases: A Report from the Blood and Marrow Transplant Clinical Trials Network

scientific article published on 05 February 2020

Production of genetically modified Epstein-Barr virus-specific cytotoxic T cells for adoptive transfer to patients at high risk of EBV-associated lymphoproliferative disease

artículo científico publicado en 1995

Production of good manufacturing practice-grade cytotoxic T lymphocytes specific for Epstein-Barr virus, cytomegalovirus and adenovirus to prevent or treat viral infections post-allogeneic hematopoietic stem cell transplant

artículo científico publicado en 2012

Prompt versus preemptive intervention for EBV lymphoproliferative disease

scientific article published on 29 January 2004

Psychological effects of bone marrow transplantation on children and adolescents: preliminary report of a longitudinal study

artículo científico publicado el 1 de junio de 1995

Quantification of a low cellular immune response to aid in identification of pediatric liver transplant recipients at high-risk for EBV infection

artículo científico publicado en 2006

Quantitative EBV viral loads and immunosuppression alterations can decrease PTLD incidence in pediatric liver transplant recipients

artículo científico publicado en 2005

Randomized controlled trials of autologous hematopoietic stem cell transplantation for autoimmune diseases: the evolution from myeloablative to lymphoablative transplant regimens

artículo científico publicado en 2006

Rapidly generated multivirus-specific cytotoxic T lymphocytes for the prophylaxis and treatment of viral infections

artículo científico publicado en 2012

Recent advances in T-cell immunotherapy for haematological malignancies

artículo científico publicado en 2016

Reconstitution of adenovirus-specific cell-mediated immunity in pediatric patients after hematopoietic stem cell transplantation

artículo científico publicado en 2007

Reconstitution of the T cell receptor alpha beta repertoire in recipients of allogeneic BMT

artículo científico publicado el 1 de diciembre de 1992

Regression of experimental medulloblastoma following transfer of HER2-specific T cells

artículo científico publicado en 2007

Replication-competent retroviruses in gene-modified T cells used in clinical trials: is it time to revise the testing requirements?

artículo científico publicado en 2012

Reply to S. Yuan et al.

artículo científico publicado en 2014

Requirements for the adoptive transfer of antibody responses to a priming antigen in man.

artículo científico publicado en 1990

Response of steroid-resistant graft-versus-host disease to lymphoblast antibody CBL1 ⬇️

artículo científico publicado el 23 de septiembre de 1995

Reversal of tumor immune inhibition using a chimeric cytokine receptor

artículo científico publicado en 2014

Robust T cell responses to aspergillosis in chronic granulomatous disease: implications for immunotherapy

artículo científico publicado en 2013

Robust and cost effective expansion of human regulatory T cells highly functional in a xenograft model of graft-versus-host disease

artículo científico publicado en 2012

Safer CARS.

artículo científico publicado en 2010

Safety and clinical efficacy of rapidly-generated trivirus-directed T cells as treatment for adenovirus, EBV, and CMV infections after allogeneic hematopoietic stem cell transplant

artículo científico publicado en 2013

Seek and You Will Not Find: Ending the Hunt for Replication-Competent Retroviruses during Human Gene Therapy

artículo científico publicado en 2017

Selective depletion of a minor subpopulation of B-chronic lymphocytic leukemia cells is followed by a delayed but progressive loss of bulk tumor cells and disease regression

artículo científico publicado en 2009

Selective depletion of donor alloreactive T cells without loss of antiviral or antileukemic responses

artículo científico publicado en 2003

Selective elimination of a chemoresistant side population of B-CLL cells by cytotoxic T lymphocytes in subjects receiving an autologous hCD40L/IL-2 tumor vaccine

artículo científico publicado en 2010

Serial Activation of the Inducible Caspase 9 Safety Switch After Human Stem Cell Transplantation

artículo científico publicado en 2015

Setting Global Standards for Stem Cell Research and Clinical Translation: The 2016 ISSCR Guidelines

artículo científico publicado en 2016

Spontaneous and interleukin 2 induced secretion of tumour necrosis factor and gamma interferon following autologous marrow transplantation or chemotherapy

artículo científico publicado en 1989

Successful treatment of stem cell graft failure in pediatric patients using a submyeloablative regimen of campath-1H and fludarabine

artículo científico publicado en 2008

Survival outcomes of allogeneic hematopoietic cell transplants with EBV-positive or EBV-negative post-transplant lymphoproliferative disorder, A CIBMTR study

artículo científico publicado en 2019

Survivin-specific T cell receptor targets tumor but not T cells

artículo científico publicado en 2014

Sustained complete responses in patients with lymphoma receiving autologous cytotoxic T lymphocytes targeting Epstein-Barr virus latent membrane proteins

artículo científico publicado en 2013

Systemic inflammatory response syndrome after administration of unmodified T lymphocytes

artículo científico publicado en 2014

T cell receptor repertoire of CD4+ and CD8+ T cell subsets in the allogeneic bone marrow transplant recipient ⬇️

artículo científico publicado el 1 de agosto de 1995

T cell therapies

artículo científico publicado en 2006

T cell therapy in allogeneic stem cell transplantation

artículo científico publicado en 2008

T cells for viral infections after allogeneic hematopoietic stem cell transplant

scientific article published on 20 May 2016

T lymphocytes coexpressing CCR4 and a chimeric antigen receptor targeting CD30 have improved homing and antitumor activity in a Hodgkin tumor model.

artículo científico publicado en 2009

T lymphocytes redirected against the kappa light chain of human immunoglobulin efficiently kill mature B lymphocyte-derived malignant cells

artículo científico publicado en 2006

T lymphocytes targeting native receptors

artículo científico publicado en 2014

T-Cell Receptor Stimulation Enhances the Expansion and Function of CD19 Chimeric Antigen Receptor-Expressing T Cells

artículo científico publicado en 2019

T-cell immunotherapy for adenoviral infections of stem-cell transplant recipients

artículo científico publicado en 2005

T-cell immunotherapy: looking forward

artículo científico publicado en 2014

T-cell receptor sequencing demonstrates persistence of virus-specific T cells after antiviral immunotherapy

artículo científico publicado en 2019

T-cell therapy for viral infections

artículo científico publicado en 2013

T-cell therapy in the treatment of post-transplant lymphoproliferative disease

artículo científico publicado en 2012

T-cell-based therapies for malignancy and infection in childhood

artículo científico publicado en 2010

TCR expression; quantitative easing by CD3

scientific article published on 01 September 2011

TNF and chronic B lymphoproliferative disorders

artículo científico publicado en 1993

TanCAR: A Novel Bispecific Chimeric Antigen Receptor for Cancer Immunotherapy ⬇️

artículo científico publicado el 9 de julio de 2013

The clone ranger?

artículo científico publicado en 2008

The costs and cost-effectiveness of allogeneic peripheral blood stem cell transplantation versus bone marrow transplantation in pediatric patients with acute leukemia

artículo científico publicado en 2010

The generation and characterization of LMP2-specific CTLs for use as adoptive transfer from patients with relapsed EBV-positive Hodgkin disease

artículo científico publicado en 2004

The immunogenicity of virus-derived 2A sequences in immunocompetent individuals ⬇️

artículo científico publicado el 23 de mayo de 2013

The safety and clinical effects of administering a multiantigen-targeted T cell therapy to patients with multiple myeloma

artículo científico publicado en 2020

The t(9;22) translocation in Philadelphia-positive essential thrombocythaemia does not involve the T lymphocyte lineage

artículo científico publicado en 1990

The use of chimeric antigen receptor T cells in patients with non-Hodgkin lymphoma

The use of cytotoxic t cells for the prevention and treatment of epstein-barr virus induced lymphoma in transplant recipients

artículo científico publicado en 2000

Transduction of CD34(+) and CD34(-)/lin(-) hemopoietic progenitors by lentivirus vectors

artículo científico publicado en 1999

Transfer of EBV-specific CTL to prevent EBV lymphoma post bone marrow transplant

artículo científico publicado en 1999

Transfer of marker genes into hemopoietic progenitor cells

artículo científico publicado el 1 de septiembre de 1996

Transfusion-related acute lung injury (TRALI) following allogeneic stem cell transplant for acute myeloid leukemia

artículo científico publicado en 2004

Transmission of integrated human herpesvirus-6 in allogeneic hematopoietic stem cell transplantation

artículo científico publicado en 2007

Treatment of Epstein-Barr virus lymphoproliferative disease after hematopoietic stem-cell transplantation with hydroxyurea and cytotoxic T-cell lymphocytes

artículo científico publicado en 2004

Treatment of Epstein-Barr virus-associated malignancies with specific T cells

artículo científico publicado en 2002

Treatment of nasopharyngeal carcinoma with Epstein-Barr virus--specific T lymphocytes

artículo científico publicado en 2004

Treatment of relapsed Hodgkin's disease using EBV-specific cytotoxic T cells

artículo científico publicado en 1998

Treatment of solid organ transplant recipients with autologous Epstein Barr virus-specific cytotoxic T lymphocytes (CTLs)

artículo científico publicado en 2006

Treatment of steroid-refractory acute graft-versus-host disease with anti-CD147 monoclonal antibody ABX-CBL.

artículo científico publicado en 2001

Tumor indoleamine 2,3-dioxygenase (IDO) inhibits CD19-CAR T cells and is downregulated by lymphodepleting drugs

artículo científico publicado en 2015

Tumor necrosis factor mediates autocrine growth inhibition in a chronic leukemia

scientific article published on 01 December 1989

Tumor response and endogenous immune reactivity after administration of HER2 CAR T cells in a child with metastatic rhabdomyosarcoma

scientific article published on 15 July 2020

Tumor-Specific T-Cells Engineered to Overcome Tumor Immune Evasion Induce Clinical Responses in Patients With Relapsed Hodgkin Lymphoma

artículo científico publicado en 2018

Tumour necrosis factor as an autocrine tumour growth factor for chronic B-cell malignancies

scientific article published on 01 April 1988

Ultra low-dose IL-2 for GVHD prophylaxis after allogeneic hematopoietic stem cell transplantation mediates expansion of regulatory T cells without diminishing antiviral and antileukemic activity.

artículo científico publicado en 2014

Use of Chimeric Antigen Receptor T Cell Therapy in Clinical Practice for Relapsed/Refractory Aggressive B Cell Non-Hodgkin Lymphoma: An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy

scientific article published on 22 August 2019

Use of cytokine polymorphisms and Epstein-Barr virus viral load to predict development of post-transplant lymphoproliferative disorder in paediatric liver transplant recipients

artículo científico publicado en 2006

Use of double marking with retroviral vectors to determine rate of reconstitution of untreated and cytokine expanded CD34+ selected marrow cells in patients undergoing autologous bone marrow transplantation

artículo científico publicado en 1996

Use of gene marking in bone marrow transplantation

scientific article published on 01 January 1996

Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation

artículo científico publicado en 1995

Viral lymphomagenesis

artículo científico publicado en 2006

Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma

artículo científico publicado en 2008

XomaZyme-CD5 immunotoxin in conjunction with partial T cell depletion for prevention of graft rejection and graft-versus-host disease after bone marrow transplantation from matched unrelated donors

artículo científico publicado en 1994

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda